Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

SkyePharma and GeneMedix to develop extended-release interferon alfa-2b

July 5, 2002

Hepatitis B pharmaccine enters phase II

July 3, 2002

Incara submits IND for liver cell transplantation

July 1, 2002

Pegasys approved in E.U.

June 26, 2002

Remicade launched in Japan for Crohn's disease

June 26, 2002

Antiinflammatory activity of IS-741 in experimental colitis

June 21, 2002

Immtech's lead hepatitis C compounds to be validated for further development

June 20, 2002

Chiron grants nonexclusive HCV license to Merck & Co.

June 20, 2002

Potential antiulcer drug from natural sources under study in Chile

June 19, 2002

Novel proton pump inhibitor prodrugs prepared and tested at Takeda

June 14, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...